Cellectis S.A. American Depositary Shares (CLLS)
Cellectis S.A. American Depositary Shares
XNAS:CLLS
4.1
$4.15 - 100.00
$4.05 - 974.00
$4.01
$4.26
$4.25
$4.79
5.48
1.1
44242
111768.3
61494182.65
Chart
TendieTensor AI Analysis
Company
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Fundamentals
222
-14.370000
4.672900
100
BBG0084L1XN2
BBG0084L1YD1
72.09M
100.33M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own CLLS. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.